TCL set up a Biotech facility in 2002, to develop processes to produce nature identical chiral products based on bio-transformation using biocatalysts. The TCL R & D and Biotechnology Teams developed the complex technology involving Biology, Chemistry, Polymer Chemistry and Separation Techniques.

To demonstrate the commercial viability of the process developed, we set up a Pilot Plant designed and built by our Engineering Team, with facility for scale up.  

After nearly four years of concerted team effort this product has been successfully commercialized.

The project from Research to Commercial production is yet another demonstration of our competencies in a new area.